PGR and breast cancer: Musgrove et al. illustrated that progesterone treatment of PR-positive breast cancer cells results in an increase in cell cycle progression, which is correlated with an induction of cell cycle genes; including cyclin D1 (25, 26), and c-Myc (25–27).